Acrivon Therapeutics, Inc. · NASDAQ:ACRV

Perceptive Advisors LLC reported a 9.90% stake in Acrivon Therapeutics, Inc. (Schedule 13G/A)

Event Apr 29, 2025 · Filed May 1, 2025

Perceptive Advisors LLC reported a 9.90% stake in Acrivon Therapeutics, Inc., 3,104,139 shares, as a passive investor on Apr 29, 2025. Filed May 1, 2025 (Schedule 13G/A).

Stake
9.90%
Shares
3,104,139
Intent
Passive
What changed
Stake changed
Filed together
3 holders

The filing in full

HolderStakeShares
Perceptive Advisors LLC9.90%3,104,139
Joseph Edelman9.90%3,104,139
Perceptive Life Sciences Master Fund, Ltd.9.90%3,104,139

Source

View original at SEC

Related